Image Source: © Demidovichphotostock | Megapixl.com
- Holista Colltech is going strong in the current fiscal year 2022 following a year of achievements.
- Revenue grew 13% to record AU$8 million, while net loss before tax narrowed significantly in FY21.
- Sales receipts touched all-time high in the March 2022 quarter with significant growth across divisions.
- New products, global partnerships and other growth factors are expected to fuel a stronger 2022.
Holista Colltech Limited (ASX:HCT) is an emerging Australian developer of health and wellness products in the US$4.4 trillion global health and wellness industry.
The year 2021 marked a strong rebound for the company with remarkable growth across its business divisions. The strong performance paved the company’s way to a stronger 2022 with great prospects of significant developments in its product portfolio and business expansion worldwide.
2021 – A Year of Achievements
Holista ended the fiscal year 2021 with double-digit growth in three out of four of the divisions. The company’s revenue for FY21 touched record value of AU$8 million, 13% higher than the COVID-19 impacted FY20.
There was strong growth across business units – 18% in Dietary Supplements, 33% in Healthy Food Ingredients and 43% in Olive Collagen. Also, Holista’s newest division of Infection Control saw strong demand for sanitising solutions.
The solid growth can be attributed to great initiatives and developments at various levels. Have a look!
Source: Company announcement
Holista set for a magnificent leap up in 2022
Holista has set the ball rolling for the fiscal year 2022 with a sharp jump in the first quarter of 2022.
The firm posted high quarterly sales receipts worth AU$2.4 million, representing 34% growth on prior comparable period (pcp). The total sales of the company including all the four divisions went up to AU$2.7 million, 42% higher on pcp.
Several growth drivers including new product launches and partnerships are expected to accelerate the ASX-listed company’s growth momentum in 2022.
Furthermore, rising demand for most of Holista’s products in the global market would contribute to its uprearing performance by a great deal in the coming quarters. On this front, the company has been investing heavily in building inventory of raw materials.
Stock information: HCT shares traded at AU$0.031 on 2 June 2022, with market capitalisation of AU$8.53 million.
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and